Meet Cromos Pharma at ESMO Congress 2022 in Paris
We at Cromos Pharma are happy to announce that our CEO, Vlad Bogin, and our US Business Development Director, Nicole Brenna, will be attending the ESMO Congress 2022, which will be held on September 9-13 in Paris, France.
About ESMO Congress
ESMO Congress is an annual gathering hosted by the European Society for Medical Oncology (ESMO) designed to bring together oncology professionals, researchers, healthcare industry representatives, and policymakers from more than 160 countries to network with their respective peers and discuss the latest scientific advancements in the field of medical oncology and the best ways to incorporate them in routine patient care.
Cromos Pharma at ESMO Congress 2022
Given Cromos Pharma’s extensive experience in managing various aspects of oncology clinical trials, this gathering is particularly relevant to our company as it allows us to share our expertise and network with a wide range of professionals related to our work.
The ESMO Congress 2022 will be attended by the founder and CEO of Cromos Pharma, Vlad Bogin, and our Business Development Director, Nicole Brenna, both of whom will be delighted to learn about your clinical development plans and discuss ways in which Cromos Pharma can provide support.
We look forward to meeting you there and hope to form long-term, mutually beneficial partnerships with you or your company. Meet them in person or set up a virtual call you can by emailing bd@cromospharma.com.
About Cromos Pharma
Cromos Pharma is a US-based, international contract research organization delivering fully integrated clinical research solutions, in all trial phases, across a wide range of therapeutic indications. Our expert team, comprised of 95% MDs, has extensive expertise in study design, medical writing, regulatory affairs, site management, patient recruitment and data management.
Cromos Pharma has experience in delivering success in a wide range of trial types, from biosimilars and generics, to successfully managing trials of novel therapeutics in a wide range of clinical indications. Our team provides full-service solutions to international pharma and biotech companies in high-recruiting regions, assuring exceptional data quality. Cromos Pharma combines global expertise with in-depth experience and knowledge in the US, Central and Eastern Europe, Central Asia, Republic of Georgia, and Türkiye to offer exceptional patient recruitment. Our team has met or reduced enrollment timelines in 95% of conducted trials.
We provide accelerated study start-up timelines in our regions of operation. Regulatory inspections by FDA and EMA and site audits attest to the highest quality of our clinical data.
Established in 2004, Cromos Pharma has strong regional experience that is supported by a global network of offices. Its international HQ is located in Portland, Oregon, USA and its European HQ is in Dublin, Ireland.
